OncoSec

1 follower


OncoSec is a biotechnology company pioneering new technologies to stimulate the body’s immune system to target and attack cancer. Through its proprietary DNA gene transfer technology, OncoSec seeks to deliver safer and more effective cancer treatments that can provide long-term benefits for patients... Read more

Industries

Headquarters

Stage

Employees

Links

Org chart

Sandra Aung
SVP, Chief Clinical Development Officer
Bridget O'Keeffe
VP, Clinical Development
Jeff Silverman
VP, Product Engineering
Gregory Solz, RQAP-GCP, CQM, CQA
Vice President / Management Representative Quality (GxP)